SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-13-378663
Filing Date
2013-09-25
Accepted
2013-09-25 17:27:16
Documents
8
Effectiveness Date
2013-09-25

Document Format Files

Seq Description Document Type Size
1 S-8 d596972ds8.htm S-8 57885
2 EX-4.1 d596972dex41.htm EX-4.1 73932
3 EX-4.2 d596972dex42.htm EX-4.2 74715
4 EX-4.3 d596972dex43.htm EX-4.3 14306
5 EX-4.4 d596972dex44.htm EX-4.4 147116
6 EX-4.5 d596972dex45.htm EX-4.5 46001
7 EX-5.1 d596972dex51.htm EX-5.1 4555
8 EX-23.1 d596972dex231.htm EX-23.1 2451
  Complete submission text file 0001193125-13-378663.txt   421961
Mailing Address 225 PROMENADE DU CENTROPOLIS, SUITE 200 LAVAL A8 H7T 3B3
Business Address 225 PROMENADE DU CENTROPOLIS, SUITE 200 LAVAL A8 H7T 3B3 (450) 687-2262
Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0228
Type: S-8 | Act: 33 | File No.: 333-191383 | Film No.: 131115177
SIC: 2834 Pharmaceutical Preparations